International consensus statement on allergy and rhinology: Allergic rhinitis–2023

SK Wise, C Damask, LT Roland, C Ebert… - International forum of …, 2023 - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

CD39/CD73/A2AR pathway and cancer immunotherapy

C **a, S Yin, KKW To, L Fu - Molecular cancer, 2023 - Springer
Cancer development is closely associated with immunosuppressive tumor
microenvironment (TME) that attenuates antitumor immune responses and promotes tumor …

Cellular and molecular mechanisms of allergic asthma

ZI Komlósi, W van de Veen, N Kovács, G Szűcs… - Molecular aspects of …, 2022 - Elsevier
Asthma is a chronic disease of the airways, which affects more than 350 million people
worldwide. It is the most common chronic disease in children, affecting at least 30 million …

The emerging role of regulatory cell-based therapy in autoimmune disease

F Ghobadinezhad, N Ebrahimi, F Mozaffari… - Frontiers in …, 2022 - frontiersin.org
Autoimmune disease, caused by unwanted immune responses to self-antigens, affects
millions of people each year and poses a great social and economic burden to individuals …

Role of interleukin-6-mediated inflammation in the pathogenesis of inflammatory bowel disease: focus on the available therapeutic approaches and gut microbiome

A Shahini, A Shahini - Journal of Cell Communication and Signaling, 2023 - Springer
Inflammatory bowel disease (IBD) is considered a chronic inflammatory and multifactorial
disease of the gastrointestinal tract. Crohn's disease (CD) and ulcerative colitis (UC) are two …

Roles and mechanisms of tumour-infiltrating B cells in human cancer: a new force in immunotherapy

E Zhang, C Ding, S Li, X Zhou, B Aikemu, X Fan… - Biomarker …, 2023 - Springer
Immune checkpoint inhibitors (ICIs) targeting PD-1 or PD-L1 have emerged as a
revolutionary treatment strategy for human cancer patients. However, as the response rate to …

B lymphocytes ameliorate Alzheimer's disease-like neuropathology via interleukin-35

W Feng, Y Zhang, S Ding, S Chen, T Wang… - Brain, behavior, and …, 2023 - Elsevier
Increasing evidence supports the involvement of the peripheral immune system in the
pathogenesis of Alzheimer's disease (AD). In the present study, we found that B lymphocytes …

Molecular allergology and its impact in specific allergy diagnosis and therapy

D Barber, A Diaz‐Perales, MM Escribese… - Allergy, 2021 - Wiley Online Library
Progressive knowledge of allergenic structures resulted in a broad availability of allergenic
molecules for diagnosis. Component‐resolved diagnosis allowed a better understanding of …

[HTML][HTML] Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets

MC Glass, DR Glass, JP Oliveria, B Mbiribindi… - Cell reports, 2022 - cell.com
Regulatory B cells (Bregs) suppress immune responses through the secretion of interleukin-
10 (IL-10). This immunomodulatory capacity holds therapeutic potential, yet a definitional …

Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity?

O Palomares, D Elewaut, PM Irving, X Jaumont… - Allergy, 2022 - Wiley Online Library
Autoimmune diseases have a prevalence of approximately 7 to 9% and are classified as
either organ‐specific diseases, including type I diabetes, multiple sclerosis, inflammatory …